Latest News
Discontinuation of Nutrimore Neuropar – Joint Statement from Moleac and PT Prima Medika Laboratories
Discontinuation of Nutrimore Neuropar – Joint Statement from Moleac and PT Prima Medika Laboratories
ANNOUNCEMENT – INDONESIA We are pleased to share a joint…
Alvina KhooSeptember 11, 2024
Today is World Alzheimer’s Day: Raising Awareness and Helping Patients Reconnect with Their Lives
World Alzheimer’s Day is just around the corner! At Moleac,…
Alvina KhooSeptember 9, 2024
Shaping the Future of Alzheimer’s Care: Moleac at ASAD 2024 in Malaysia
Moleac was thrilled to participate in ASAD 2024 in Penang,…
Alvina KhooAugust 30, 2024
Promoting Stroke Recovery: Highlights from the Stroke Society of the Philippines Annual Convention
Last week, we were delighted to attend the Stroke Society…
Alvina KhooAugust 27, 2024
Upcoming S.H.A.P.E.S Webinar: Managing Post-Stroke Seizures
Pleased to support S.H.A.P.E.S with their upcoming webinar on Post-Stroke…
Alvina KhooAugust 27, 2024
Empowering Stroke Care: Moleac at the National Scientific Congress on Stroke in Vietnam
Together with EVD Pharma, our distributor in Vietnam, we were…
Alvina KhooAugust 14, 2024
Advancing Alzheimer’s Management: Highlights from Our Scientific Session in Malta
Moleac was thrilled to participate in ASAD 2024 in Penang,…
Alvina KhooAugust 5, 2024
Understanding Prestroke Cognitive Impairment: Key Findings from Mele et al.’s Study
STROKE CLINICAL STUDY HIGHLIGHTS – Prestroke Cognitive Impairment: Frequency and…
Alvina KhooJuly 29, 2024
Unlocking Potential: Webinar on Post-Stroke Recovery Therapies with Asian Stroke Advisory Panel
Moleac is delighted to support the upcoming webinar on Pharmacological…
Alvina KhooJuly 19, 2024
Advancing Stroke Management: Highlights from Our Stroke Workshop in Langkawi
Last weekend, we hosted an insightful Stroke Workshop in the…
Alvina KhooJuly 6, 2024
NeuroAiD™ Launches in Bahrain: Transforming Post-Stroke Recovery
Moleac is thrilled to announce the successful launch of NeuroAiD™…
Alvina KhooJuly 3, 2024
Latest videos
Patient Testimonials
Disclaimers: NeuroAiD™ II is a trademark of Moleac. MLC601 and MLC901 are 2 different proprietary formulations which have been shown to be equivalent in pharmacology and are referred as NeuroAiD on this webpage.
Find out if NeuroAiD is right for you.
Leave your questions to our Customer Care team by clicking on the box below. Always seek advice from your physician.
